Association of rare variants in ARSA with Parkinson's disease
Senkevich, K.; Beletskaia, M.; Dworkind, A.; Yu, E.; Ahmad, J.; Ruskey, J. A.; Asayesh, F.; Spiegelman, D.; Fahn, S.; Waters, C.; Monchi, O.; Dauvilliers, Y.; Dupre, N.; Greenbaum, L.; Hassin-Baer, S.; Nagornov, I.; Tyurin, A.; Miliukhina, I.; Timofeeva, A.; Emelyanov, A.; Zakharova, E.; Alcalay, R. N.; Pchelina, S.; Gan-Or, Z.
Show abstract
BackgroundSeveral lysosomal genes are associated with Parkinsons disease (PD), yet the association between PD and ARSA, which encodes for the enzyme arylsulfatase A, remains controversial. ObjectivesTo evaluate the association between rare ARSA variants and PD. MethodsTo study possible association of rare variants (minor allele frequency<0.01) in ARSA with PD, we performed burden analyses in six independent cohorts with a total of 5,801 PD patients and 20,475 controls, using optimized sequence Kernel association test (SKAT-O), followed by a meta-analysis. ResultsWe found evidence for an association between functional ARSA variants and PD in four independent cohorts (P[≤]0.05 in each) and in the meta-analysis (P=0.042). We also found an association between loss-of-function variants and PD in the UKBB cohort (P=0.005) and in the meta-analysis (P=0.049). However, despite replicating in four independent cohorts, these results should be interpreted with caution as no association survived correction for multiple comparisons. Additionally, we describe two families with potential co-segregation of the ARSA variant p.E384K and PD. ConclusionsRare functional and loss-of-function ARSA variants may be associated with PD. Further replication in large case-control cohorts and in familial studies is required to confirm these associations.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Dopamine pathway and Parkinson’s risk variants are associated with levodopa-induced dyskinesia 98%
- Polygenic Parkinson’s disease genetic risk score as risk modifier of parkinsonism in Gaucher disease 97%
- Penetrance of Parkinson’s disease in LRRK2 p.G2019S carriers is modified by a polygenic risk score 97%
Similar papers in this journal
- Large-scale genetic characterization of Parkinson’s disease in the African and African admixed populations 98%
- Genetic Analysis and Natural History of Parkinson’s Disease Due to the LRRK2 G2019S Variant 98%
- Heterozygous PRKN mutations are common but do not increase the risk of Parkinson’s disease 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.